A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
Publisher： John Wiley & Sons Inc
E-ISSN： 1521-4141|42|1|101-109
ISSN： 0014-2980
Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.42, Iss.1, 2012-01, pp. : 101-109
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
